![Jonathan Haug](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Jonathan R.
Haug is Chief Executive Officer at ARMO Biosciences, Inc. and DICE Therapeutics, Inc. Mr. Haug is President & Director at Morphic Holding, Inc. Mr. Haug is President & Director at Adverum Biotechnologies, Inc. starting in 2025.
Mr. Haug is President at Verve Therapeutics, Inc. starting in 2025.
Mr. Haug is President & Director at Ventyx Biosciences, Inc. starting in 2026.
Mr. Haug was Chief Executive Officer at Prevail Therapeutics, Inc.
Postes actifs de Jonathan Haug
| Sociétés | Poste | Début |
|---|---|---|
| VERE THER | President | 25/07/2025 |
| ADVERUM BIOTECHNOLOGIES, INC. | President | 09/12/2025 |
| VENTYX BIOSCIENCES, INC. | President | 04/03/2026 |
| MORC HOLD | President | - |
| ARMO BIOSCIENCES INC | Directeur Général | - |
| DICE THER | Directeur Général | - |
Anciens postes connus de Jonathan Haug
| Sociétés | Poste | Fin |
|---|---|---|
| PREVAIL THERAPEUTICS INC. | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology Develops oral immunology and other therapeutic products | Health Technology |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for neurodegenerative diseases | Health Technology |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
